CORT
NASDAQ · Pharmaceuticals
Corcept Therapeutics Inc
$52.28
+1.23 (+2.41%)
Performance
1D
—
1W
—
1M
—
3M
+26.56%
6M
-30.75%
1Y
-25.56%
YTD
+36.86%
Open$51.05
Previous Close$51.05
Day High$52.48
Day Low$50.32
52W High$91.00
52W Low$28.66
Volume—
Avg Volume1.30M
Market Cap5.62B
P/E Ratio118.66
EPS$0.35
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$53.13
Below
SMA 200
$69.00
Below
RSI (14)
26
Oversold
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+95.7% upside
Current
$52.28
$52.28
Target
$102.33
$102.33
$62.31
$102.33 avg
$121.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 681.87M | 551.05M | 785.70M |
| Net Income | 89.24M | 64.91M | 178.89M |
| Profit Margin | 13.1% | 12.4% | 22.8% |
| EBITDA | 41.14M | 31.59M | 255.84M |
| Free Cash Flow | — | — | 116.31M |
| Rev Growth | +23.7% | +23.7% | +17.7% |
| Debt/Equity | — | — | 0.15 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |